Come up with a name for your new list and we'll add to it:
Euclises Pharmaceuticals raised a round of funding on June 12, 2012. Investors include
St. Louis Arch Angels.
Euclises Pharmaceuticals (Euclises) is a drug discovery and development company focused on novel cyclooxygenase-2 (COX-2) inhibitors for use in the oncology setting. Euclises has developed a portfolio…